Literature DB >> 10206271

In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model.

P L Stroner1, D H Brewster, J A Dewar, O Eremin, A Gould, G C Howard, S B Kaye.   

Abstract

The Scottish Cancer Therapy Network (SCTN) was created against a background of rising concerns about perceived variation in the quality of care available to patients with cancer. SCTN has established itself as a major organization with the necessary recognition and infrastructure to provide leadership, support and impetus in the field of clinical guidelines, clinical audit and clinical trials of cancer therapy in Scotland. Since being formed in 1993, SCTN has been instrumental in the development of three evidence-based, clinical guidelines and in the completion of detailed, national, retrospective audits of the treatment of five major tumour sites. The infrastructure has been used successfully to support and encourage trial participation. Challenges for the future are a re-orientation towards prospective audit, widening the constituency and sense of ownership of SCTN as a resource for practising clinicians, and further increasing recruitment into clinical trials.

Entities:  

Mesh:

Year:  1999        PMID: 10206271      PMCID: PMC2362781          DOI: 10.1038/sj.bjc.6690262

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992.

Authors:  D H Brewster; J Crichton; J C Harvey; G Dawson
Journal:  Public Health       Date:  1997-09       Impact factor: 2.427

2.  Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research.

Authors:  J F Smyth; J Mossman; R Hall; S Hepburn; R Pinkerton; M Richards; N Thatcher; J Box
Journal:  BMJ       Date:  1994-08-13

3.  Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.

Authors:  C S McArdle; D Hole
Journal:  BMJ       Date:  1991-06-22

4.  Benefits and limitations of pathology databases to cancer registries.

Authors:  D H Brewster; J Crichton; J C Harvey; G Dawson; E R Nairn
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

5.  Entry into clinical trials in breast cancer: the importance of specialist teams. Scottish Breast Cancer Focus Group and Scottish Cancer Therapy Network.

Authors:  C J Twelves; C S Thomson; J Young; A Gould
Journal:  Eur J Cancer       Date:  1998-06       Impact factor: 9.162

6.  Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland.

Authors:  C R Gillis; D J Hole
Journal:  BMJ       Date:  1996-01-20

7.  Management of ovarian cancer: referral to a multidisciplinary team matters.

Authors:  E J Junor; D J Hole; C R Gillis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

8.  Variation in the survival of women with breast cancer in Scotland. The Scottish Breast Cancer Focus Group and The Scottish Cancer Therapy Network.

Authors:  C J Twelves; C S Thomson; A Gould; J A Dewar
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

9.  How accurate are Scottish cancer registration data?

Authors:  D Brewster; J Crichton; C Muir
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  9 in total
  1 in total

1.  Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.

Authors:  A Gregor; C S Thomson; D H Brewster; P L Stroner; J Davidson; R J Fergusson; R Milroy
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.